REQUEST A DEMO
Total
USD $0.00
Search more companies

Granfarma S.A. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers | Other Chemical and Allied Products Merchant Wholesalers | Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Granfarma S.A. Profile Updated: May 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Granfarma S.A. is a company based in Ecuador, with its head office in Quito. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was established on October 23, 2017. 11 (2023) employees currently work for Granfarma S.A.. From the latest financial highlights, Granfarma S.A. reported a net sales revenue increase of 517.29% in 2023. Its’ total assets recorded a growth of 121.54%. In 2023, Granfarma S.A.’s net profit margin decreased by 0.16%.

Headquarters
Av. Orellana E4-430, Orellana 500 Bldg.
Quito; Pichincha;

Contact Details: Purchase the Granfarma S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Granfarma S.A. report to view the information.
Outstanding Shares:
Purchase the Granfarma S.A. report to view the information.
Registered Capital:
Purchase the Granfarma S.A. report to view the information.
Incorporation Date:
October 23, 2017
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
38%
Purchase this report to view the information.
31%
Purchase this report to view the information.
31%
Company Performance
Financial values in the chart are available after Granfarma S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
517.29%
Total operating revenue
517.29%
Operating profit (EBIT)
640.61%
EBITDA
702.72%
Net Profit (Loss) for the Period
40.44%
Total assets
121.54%
Total equity
0.38%
Operating Profit Margin (ROS)
0.21%
Net Profit Margin
-0.16%
Return on Equity (ROE)
0.11%
Debt to Equity Ratio
176.03%
Quick Ratio
1.34%
Cash Ratio
0.33%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?